1. Home
  2. KALA vs LBGJ Comparison

KALA vs LBGJ Comparison

Compare KALA & LBGJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • LBGJ
  • Stock Information
  • Founded
  • KALA 2009
  • LBGJ 2007
  • Country
  • KALA United States
  • LBGJ China
  • Employees
  • KALA N/A
  • LBGJ N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • LBGJ
  • Sector
  • KALA Health Care
  • LBGJ
  • Exchange
  • KALA Nasdaq
  • LBGJ NYSE
  • Market Cap
  • KALA 26.2M
  • LBGJ 24.7M
  • IPO Year
  • KALA 2017
  • LBGJ 2024
  • Fundamental
  • Price
  • KALA $3.52
  • LBGJ $1.76
  • Analyst Decision
  • KALA Strong Buy
  • LBGJ
  • Analyst Count
  • KALA 3
  • LBGJ 0
  • Target Price
  • KALA $14.00
  • LBGJ N/A
  • AVG Volume (30 Days)
  • KALA 55.2K
  • LBGJ 46.3K
  • Earning Date
  • KALA 05-14-2025
  • LBGJ 06-10-2025
  • Dividend Yield
  • KALA N/A
  • LBGJ N/A
  • EPS Growth
  • KALA N/A
  • LBGJ N/A
  • EPS
  • KALA N/A
  • LBGJ N/A
  • Revenue
  • KALA N/A
  • LBGJ $10,794,015.00
  • Revenue This Year
  • KALA N/A
  • LBGJ N/A
  • Revenue Next Year
  • KALA N/A
  • LBGJ N/A
  • P/E Ratio
  • KALA N/A
  • LBGJ N/A
  • Revenue Growth
  • KALA N/A
  • LBGJ N/A
  • 52 Week Low
  • KALA $2.92
  • LBGJ $1.02
  • 52 Week High
  • KALA $11.20
  • LBGJ $5.50
  • Technical
  • Relative Strength Index (RSI)
  • KALA 42.83
  • LBGJ N/A
  • Support Level
  • KALA $3.67
  • LBGJ N/A
  • Resistance Level
  • KALA $4.16
  • LBGJ N/A
  • Average True Range (ATR)
  • KALA 0.31
  • LBGJ 0.00
  • MACD
  • KALA 0.05
  • LBGJ 0.00
  • Stochastic Oscillator
  • KALA 34.20
  • LBGJ 0.00

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About LBGJ LI BANG INTERNATIONAL CORPORATION I

Li Bang International Corp Inc is a holding company. The firm through its subsidiaries engages in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China under its own Libang brand. In addition, its subsidiaries provide customers with comprehensive services, from commercial kitchen design in the early stage to equipment installation and after-sales maintenance.

Share on Social Networks: